1-2 of 2
Federico Fallanca, MD
Close
Sort by
Journal Articles

R-CHOP Preceded By Engineered Tumor Necrosis Factor (TNF) in Patients with Relapsed or Refractory (r/r) Primary CNS Lymphoma (PCNSL): Results of Antitumor Activity, Safety and Blood-Brain Barrier (BBB) Permeabilization in the "Ingrid" Phase II Trial

Andres JM Ferreri, MD, Teresa Calimeri, MDPhD, Gian Marco Conte, MD, Dario Cattaneo, MD, Federico Fallanca, MD, Maurilio Ponzoni, MD, Eloise Scarano, Marianna Sassone, MD, Salvatore Perrone, MD, Caterina Cecchetti, MD, Paolo Lopedote, MD, Fiorella Ilariucci, Roberta Rudà, MD, Emanuele Angelucci, MD, Carlo Visco, Francesco Pisani, MD, Alberto Fabbri, MD, Luigi Petrucci, MD, Marco Bregni, MD, Dario Marino, MDPhD, Guido Gini, MD, Fabio Ciceri, MD, Angelo Corti, MD, Nicoletta Anzalone, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1687.
https://doi.org/10.1182/blood-2018-99-118507
Published: 2018
Journal Articles

The Prognostic Role of Interim PET after First Chemotherapy Cycle and PET Sequential Evaluation of Response to ABVD in Hodgkin Lymphoma Patients - the Polish Lymphoma Research Group (PLRG) Observational Study

Jan M Zaucha, MD PhD, Bogdan Malkowski, MD, Edyta Subocz, MD, Stephane Chauvie, PhD, Joanna Tajer, MD, Waldemar Kulikowski, MD, Agnieszka Fijolek-Warszewska, MD, Alberto Biggi, MD, Federico Fallanca, MD, Malgorzata Kobylecka, MD, Miroslaw Dziuk, MD PhD, Dariusz Woszczyk, MD, Justyna Rybka, MD, Renata Kroll-Balcerzak, MD, Fabrizio Bergesio, PhD, Agnieszka Romanowicz, MD, Agnieszka Chamier-Cieminska, MD, Pawel Kurczab, MD, Agnieszka Giza, Krzysztof Lesniewski-Kmak, MD, Wanda Knopinska-Posluszny, MD PhD, Jan Walewski, MDPhDProf, Andrea Gallamini, MD
Journal: Blood
Blood (2015) 126 (23): 3943.
https://doi.org/10.1182/blood.V126.23.3943.3943
Published: 2015